Fas counterattack in cholangiocarcinoma: A mechanism for immune evasion in human hilar cholangiocarcinomas

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

188

HTML

2004

Figures (1-6)

170

Sum=2362

Dec 15, 2001 (publication date) through Jul 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Research

World J Gastroenterol. Dec 15, 2001; 7(6): 860-863
Published online Dec 15, 2001. doi: 10.3748/wjg.v7.i6.860

Full Size Figure Download Figure

Figure 3 Expression of FasL mRNA in human cholangiocarcinoma cells QBC939. M: DL 2000 Marker; 1: FasL; 2: FasL+β-actin

Citation: Li ZY, Zou SQ. Fas counterattack in cholangiocarcinoma: A mechanism for immune evasion in human hilar cholangiocarcinomas. World J Gastroenterol 2001; 7(6): 860-863
URL: https://www.wjgnet.com/1007-9327/full/v7/i6/860.htm
DOI: https://dx.doi.org/10.3748/wjg.v7.i6.860